☰

Andrew C. Wilber, Ph.D. - Publications

Affiliations: 
2006 University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Molecular Biology, Cell Biology, Genetics
Tree Info Similar researchers PubMed Report error

60 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Wang X, McKillop WM, Dlugi TA, Faber ML, Alvarez-Argote J, Chambers CB, Wilber A, Medin JA. A mass spectrometry assay for detection of endogenous and lentiviral engineered hemoglobin in cultured cells and sickle cell disease mice. The Journal of Gene Medicine. e3567. PMID 37455676 DOI: 10.1002/jgm.3567  0.308
2020 Guan Y, Chambers CB, Tabatabai T, Hatley H, Delfino KR, Robinson K, Alanee SR, Ran S, Torry DS, Wilber A. Renal cell tumors convert natural killer cells to a proangiogenic phenotype. Oncotarget. 11: 2571-2585. PMID 32655841 DOI: 10.18632/Oncotarget.27654  0.435
2020 Daniel-Moreno A, Lamsfus-Calle A, Wilber A, Chambers CB, Johnston I, Antony JS, Epting T, Handgretinger R, Mezger M. Comparative analysis of lentiviral gene transfer approaches designed to promote fetal hemoglobin production for the treatment of β-hemoglobinopathies. Blood Cells, Molecules & Diseases. 84: 102456. PMID 32498026 DOI: 10.1016/J.Bcmd.2020.102456  0.398
2020 Chambers CB, Gross J, Pratt K, Guo X, Byrnes C, Lee YT, Lavelle D, Dean A, Miller JL, Wilber A. The mRNA-Binding Protein IGF2BP1 Restores Fetal Hemoglobin in Cultured Erythroid Cells from Patients with β-Hemoglobin Disorders. Molecular Therapy. Methods & Clinical Development. 17: 429-440. PMID 32154328 DOI: 10.1016/J.Omtm.2020.01.011  0.356
2019 Volk-Draper L, Patel R, Bhattarai N, Yang J, Wilber A, DeNardo D, Ran S. Myeloid-Derived Lymphatic Endothelial Cell Progenitors Significantly Contribute to Lymphatic Metastasis in Clinical Breast Cancer. The American Journal of Pathology. PMID 31421071 DOI: 10.1016/J.Ajpath.2019.07.006  0.324
2017 Volk-Draper LD, Hall KL, Wilber AC, Ran S. Lymphatic endothelial progenitors originate from plastic myeloid cells activated by toll-like receptor-4. Plos One. 12: e0179257. PMID 28598999 DOI: 10.1371/Journal.Pone.0179257  0.362
2017 Alanee S, Delfino K, Wilber A, Robinson K, Brard L, Semaan A. Single nucleotide variant in Nucleoporin 107 may be predictive of sensitivity to chemotherapy in patients with ovarian cancer. Pharmacogenetics and Genomics. PMID 28562428 DOI: 10.1097/Fpc.0000000000000288  0.328
2017 Ran S, Wilber A. Novel role of immature myeloid cells in formation of new lymphatic vessels associated with inflammation and tumors. Journal of Leukocyte Biology. PMID 28408396 DOI: 10.1189/Jlb.1Mr1016-434Rr  0.315
2016 Villamizar O, Chambers CB, Mo YY, Torry DS, Hofstrand R, Riberdy JM, Persons DA, Wilber A. Data in support of transcriptional regulation and function of Fas-antisense long noncoding RNA during human erythropoiesis. Data in Brief. 7: 1288-95. PMID 27141526 DOI: 10.1016/J.Dib.2016.03.106  0.43
2016 Villamizar O, Chambers CB, Mo YY, Torry DS, Hofstrand R, Riberdy JM, Persons DA, Wilber A. Fas-antisense long noncoding RNA is differentially expressed during maturation of human erythrocytes and confers resistance to Fas-mediated cell death. Blood Cells, Molecules & Diseases. 58: 57-66. PMID 27067490 DOI: 10.1016/J.Bcmd.2016.03.002  0.448
2016 Villamizar O, Chambers CB, Riberdy JM, Persons DA, Wilber A. Long noncoding RNA Saf and splicing factor 45 increase soluble Fas and resistance to apoptosis. Oncotarget. 7: 13810-26. PMID 26885613 DOI: 10.18632/Oncotarget.7329  0.366
2015 Pestina TI, Hargrove PW, Zhao H, Mead PE, Smeltzer MP, Weiss MJ, Wilber A, Persons DA. Amelioration of murine sickle cell disease by nonablative conditioning and γ-globin gene-corrected bone marrow cells. Molecular Therapy. Methods & Clinical Development. 2: 15045. PMID 26665131 DOI: 10.1038/Mtm.2015.45  0.49
2015 Chambers CB, Halford WP, Geltz J, Villamizar O, Gross J, Embalabala A, Gershburg E, Wilber A. A system for creating stable cell lines that express a gene of interest from a bidirectional and regulatable herpes simplex virus type 1 promoter. Plos One. 10: e0122253. PMID 25823013 DOI: 10.1371/Journal.Pone.0122253  0.553
2015 Hoban MD, Cost GJ, Mendel MC, Romero Z, Kaufman ML, Joglekar AV, Ho M, Lumaquin D, Gray D, Lill GR, Cooper AR, Urbinati F, Senadheera S, Zhu A, Liu PQ, ... ... Wilber A, et al. Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells. Blood. 125: 2597-604. PMID 25733580 DOI: 10.1182/Blood-2014-12-615948  0.44
2015 Urbinati F, Hargrove PW, Geiger S, Romero Z, Wherley J, Kaufman ML, Hollis RP, Chambers CB, Persons DA, Kohn DB, Wilber A. Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cells. Experimental Hematology. 43: 346-51. PMID 25681747 DOI: 10.1016/J.Exphem.2015.01.009  0.476
2015 Hoban MD, Mendel MC, Romero Z, Kaufman ML, Joglekar AV, Ho M, Lumaquin D, Gray D, Lill GR, Cooper AR, Urbinati F, Senadheera S, Zhu A, Liu P, Paschon DE, ... ... Wilber A, et al. 115. Correction of the Sickle-Cell Disease Mutation in Human Hematopoietic Stem/Progenitor Cells Molecular Therapy. 23. DOI: 10.1016/S1525-0016(16)33720-0  0.335
2012 Volk-Draper LD, Rajput S, Hall KL, Wilber A, Ran S. Novel model for basaloid triple-negative breast cancer: behavior in vivo and response to therapy. Neoplasia (New York, N.Y.). 14: 926-42. PMID 23097627 DOI: 10.1593/Neo.12956  0.328
2012 Liu Z, Yan R, Al-Salman A, Shen Y, Bu Y, Ma J, Luo DX, Huang C, Jiang Y, Wilber A, Mo YY, Huang MC, Zhao Y, Cao D. Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells. The Biochemical Journal. 442: 273-82. PMID 22329800 DOI: 10.1042/Bj20111322  0.374
2012 Okuda H, Kobayashi A, Xia B, Watabe M, Pai SK, Hirota S, Xing F, Liu W, Pandey PR, Fukuda K, Modur V, Ghosh A, Wilber A, Watabe K. Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells. Cancer Research. 72: 537-47. PMID 22113945 DOI: 10.1158/0008-5472.Can-11-1678  0.32
2011 Kobayashi A, Okuda H, Xing F, Pandey PR, Watabe M, Hirota S, Pai SK, Liu W, Fukuda K, Chambers C, Wilber A, Watabe K. Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone. The Journal of Experimental Medicine. 208: 2641-55. PMID 22124112 DOI: 10.1084/Jem.20110840  0.341
2011 Wilber A, Ulloa Montoya F, Hammer L, Moriarity BS, Geurts AM, Largaespada DA, Verfaillie CM, McIvor RS, Lakshmipathy U. Efficient non-viral integration and stable gene expression in multipotent adult progenitor cells. Stem Cells International. 2011: 717069. PMID 21977042 DOI: 10.4061/2011/717069  0.66
2011 Groesch KA, Torry RJ, Wilber AC, Abrams R, Bieniarz A, Guilbert LJ, Torry DS. Nitric oxide generation affects pro- and anti-angiogenic growth factor expression in primary human trophoblast. Placenta. 32: 926-31. PMID 21963217 DOI: 10.1016/J.Placenta.2011.08.008  0.33
2011 Wilber A, Nienhuis AW, Persons DA. Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities. Blood. 117: 3945-53. PMID 21321359 DOI: 10.1182/Blood-2010-11-316893  0.423
2011 Pandey PR, Okuda H, Watabe M, Pai SK, Liu W, Kobayashi A, Xing F, Fukuda K, Hirota S, Sugai T, Wakabayashi G, Koeda K, Kashiwaba M, Suzuki K, Chiba T, ... ... Wilber AC, et al. Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase. Breast Cancer Research and Treatment. 130: 387-98. PMID 21188630 DOI: 10.1007/S10549-010-1300-6  0.383
2011 Wilber A, Hargrove PW, Kim YS, Riberdy JM, Sankaran VG, Papanikolaou E, Georgomanoli M, Anagnou NP, Orkin SH, Nienhuis AW, Persons DA. Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer. Blood. 117: 2817-26. PMID 21156846 DOI: 10.1182/Blood-2010-08-300723  0.461
2011 Pandey PR, Okuda H, Misako W, Pai SK, Liu W, Kobayashi A, Xing F, Fukuda K, Hirota S, Sugai T, Wakabayashi G, Koeda K, Kashiwaba M, Suzuki K, Chiba T, ... ... Wilber AC, et al. Abstract 979: Upregulation of lipogenic genes, SREBP-1, ACLY, ACC-1 and FAS, confer proliferation and survival advantages to cancer stem-like cells in ductal carcinoma in situ Cancer Research. 71: 979-979. DOI: 10.1158/1538-7445.Am2011-979  0.499
2010 Huang X, Haley K, Wong M, Guo H, Lu C, Wilber A, Zhou X. Unexpectedly high copy number of random integration but low frequency of persistent expression of the Sleeping Beauty transposase after trans delivery in primary human T cells. Human Gene Therapy. 21: 1577-90. PMID 20528476 DOI: 10.1089/Hum.2009.138  0.52
2010 Wilber A, Tschulena U, Hargrove PW, Kim YS, Persons DA, Barbas CF, Nienhuis AW. A zinc-finger transcriptional activator designed to interact with the gamma-globin gene promoters enhances fetal hemoglobin production in primary human adult erythroblasts. Blood. 115: 3033-41. PMID 20190190 DOI: 10.1182/Blood-2009-08-240556  0.485
2010 Multhaup M, Karlen AD, Swanson DL, Wilber A, Somia NV, Cowan MJ, McIvor RS. Cytotoxicity associated with artemis overexpression after lentiviral vector-mediated gene transfer. Human Gene Therapy. 21: 865-75. PMID 20163250 DOI: 10.1089/Hum.2009.162  0.713
2010 Rajput S, Wilber A. Roles of inflammation in cancer initiation, progression, and metastasis. Frontiers in Bioscience (Scholar Edition). 2: 176-83. PMID 20036938 DOI: 10.2741/S55  0.312
2010 Flister MJ, Wilber A, Hall KL, Iwata C, Miyazono K, Nisato RE, Pepper MS, Zawieja DC, Ran S. Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1. Blood. 115: 418-29. PMID 19901262 DOI: 10.1182/Blood-2008-12-196840  0.305
2010 Podetz-Pedersen KM, Bell JB, Steele TW, Wilber A, Shier WT, Belur LR, McIvor RS, Hackett PB. Gene expression in lung and liver after intravenous infusion of polyethylenimine complexes of Sleeping Beauty transposons. Human Gene Therapy. 21: 210-20. PMID 19761403 DOI: 10.1089/Hum.2009.128  0.668
2010 Flister MJ, Hall KL, Wilber A, Ran S. Abstract 3442: Inflammatory mediators activate lymphatic endothelial cells (LECs) through elevation of NF-κB, Prox1, and VEGFR-3 Cancer Research. 70: 3442-3442. DOI: 10.1158/1538-7445.Am10-3442  0.322
2010 Volk L, Wilber A, Desai N, Trieu V, Ran S. Abstract 3279: Nab-paclitaxel and bevacizumab treatment in new models of inflammatory breast cancer, SUM149-RR and SUM149-GL Cancer Research. 70: 3279-3279. DOI: 10.1158/1538-7445.Am10-3279  0.329
2010 Hall K, Flister M, Volk L, Curry S, Wilber A, Ran S. Abstract 2354: Angiopoietin-2 role in breast cancer metastasis Cancer Research. 70: 2354-2354. DOI: 10.1158/1538-7445.Am10-2354  0.306
2010 Volk L, Wilber A, Trieu V, Desai N, Ran S. Abstract P1-03-09: Combination ofnab-Paclitaxel and Bevacizumab Inhibited Tumor Growth and Metastasis of New Inflammatory Breast Cancer Models Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P1-03-09  0.314
2009 Huang X, Wilber A, McIvor RS, Zhou X. DNA transposons for modification of human primary T lymphocytes. Methods in Molecular Biology (Clifton, N.J.). 506: 115-26. PMID 19110623 DOI: 10.1007/978-1-59745-409-4_9  0.682
2009 Wilber A, Hargrove PW, Kim Y, Nienhuis AW, Persons DA. Lentiviral Vector-Mediated Transfer of the Gamma-Globin Gene Into Normal and Beta-Thalassemic Human CD34+ Cells Results in Potentially Therapeutic Levels of Fetal Hemoglobin in Erythroid Progeny. Blood. 114: 3579-3579. DOI: 10.1182/Blood.V114.22.3579.3579  0.424
2009 Wilber A, Tschulena U, Hargrove PW, Kim Y, Barbas CF, Persons DA, Nienhuis AW. A Zinc-Finger Transcriptional Activator Designed to Interact with the Gamma-Globin Gene Promoters Enhances Fetal Hemoglobin Production in Erythroid Cells Derived From Normal and Beta-Thalassemic CD34+ Cells. Blood. 114: 3567-3567. DOI: 10.1182/Blood.V114.22.3567.3567  0.507
2009 Wilber A, Tolar J, Blazar BR, Verfaillie CM, Lakshmipathy U, Kaufman DS, McIvor RS. Sleeping Beauty-Mediated Transposition in Stem Cells Emerging Technology Platforms For Stem Cells. 341-362. DOI: 10.1002/9780470454923.ch19  0.51
2008 Belur LR, McIvor RS, Wilber A. Liver-directed gene therapy using the sleeping beauty transposon system. Methods in Molecular Biology (Clifton, N.J.). 434: 267-76. PMID 18470650 DOI: 10.1007/978-1-60327-248-3_16  0.673
2008 Wangensteen KJ, Wilber A, Keng VW, He Z, Matise I, Wangensteen L, Carson CM, Chen Y, Steer CJ, McIvor RS, Largaespada DA, Wang X, Ekker SC. A facile method for somatic, lifelong manipulation of multiple genes in the mouse liver. Hepatology (Baltimore, Md.). 47: 1714-24. PMID 18435462 DOI: 10.1002/Hep.22195  0.653
2008 Wangensteen KJ, Wilber A, Keng VW, Chen Y, Matise I, Wangensteen L, Steer CJ, McIvor RS, Largaespada DA, Wang X, Ekker SC. A method for lifelong genetic manipulation of regenerating hepatocytes in mouse Cell Research. 18: S31-S31. DOI: 10.1038/Cr.2008.121  0.574
2007 Wilber A, Linehan JL, Tian X, Woll PS, Morris JK, Belur LR, McIvor RS, Kaufman DS. Efficient and stable transgene expression in human embryonic stem cells using transposon-mediated gene transfer. Stem Cells (Dayton, Ohio). 25: 2919-27. PMID 17673526 DOI: 10.1634/Stemcells.2007-0026  0.729
2007 Wilber A, Wangensteen KJ, Chen Y, Zhuo L, Frandsen JL, Bell JB, Chen ZJ, Ekker SC, McIvor RS, Wang X. Messenger RNA as a source of transposase for sleeping beauty transposon-mediated correction of hereditary tyrosinemia type I. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 1280-7. PMID 17440442 DOI: 10.1038/Sj.Mt.6300160  0.656
2007 Woll PS, Cameron C, Wilber A, Linehan JL, Kaufman DS. Cellular and genetic advances in analysis of hematopoietic development from human embryonic stem cells Blood Cells, Molecules, and Diseases. 38: 148. DOI: 10.1016/J.Bcmd.2006.10.069  0.343
2006 Balciunas D, Wangensteen KJ, Wilber A, Bell J, Geurts A, Sivasubbu S, Wang X, Hackett PB, Largaespada DA, McIvor RS, Ekker SC. Harnessing a high cargo-capacity transposon for genetic applications in vertebrates. Plos Genetics. 2: e169. PMID 17096595 DOI: 10.1371/Journal.Pgen.0020169  0.662
2006 Geurts AM, Wilber A, Carlson CM, Lobitz PD, Clark KJ, Hackett PB, McIvor RS, Largaespada DA. Conditional gene expression in the mouse using a Sleeping Beauty gene-trap transposon. Bmc Biotechnology. 6: 30. PMID 16800892 DOI: 10.1186/1472-6750-6-30  0.662
2006 Wilber A, Frandsen JL, Geurts JL, Largaespada DA, Hackett PB, McIvor RS. RNA as a source of transposase for Sleeping Beauty-mediated gene insertion and expression in somatic cells and tissues. Molecular Therapy : the Journal of the American Society of Gene Therapy. 13: 625-30. PMID 16368272 DOI: 10.1016/J.Ymthe.2005.10.014  0.709
2006 Huang X, Wilber AC, Bao L, Tuong D, Tolar J, Orchard PJ, Levine BL, June CH, McIvor RS, Blazar BR, Zhou X. Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system. Blood. 107: 483-91. PMID 16189271 DOI: 10.1182/Blood-2005-05-2133  0.706
2006 Wilber A, Wangensteen KJ, Chen Y, Zhou L, Frandsen JL, Bell J, Chen Z, Ekker SC, McIvor RS, Wang X. 405. Correction of the Murine Model of Hereditary Tyrosinemia Type I Using Messenger RNA as a Source of Transposase for Sleeping Beauty Mediated Integration of the FAH Gene Molecular Therapy. 13: S155-S156. DOI: 10.1016/J.Ymthe.2006.08.468  0.695
2006 Balciunas D, Wilber A, Wangensteen K, Bell J, Geurts A, Hackett PB, Largaespada DA, McIvor RS, Ekker SC. 385. Tol2 Transposon as a Gene Therapy Vector: Characterization, Optimization and Correction of Hereditary Tyrosinemia Type 1 in Mouse Molecular Therapy. 13: S147. DOI: 10.1016/J.Ymthe.2006.08.446  0.66
2006 Wilber A, Linehan JL, Tian X, McIvor RS, Kaufman DS. 95. Effective Genetic Engineering of Human Embryonic Stem Cells Using the Sleeping Beauty Transposon System Molecular Therapy. 13: S39. DOI: 10.1016/J.Ymthe.2006.08.114  0.712
2005 Wilber A, Frandsen JL, Wangensteen KJ, Ekker SC, Wang X, McIvor RS. Dynamic gene expression after systemic delivery of plasmid DNA as determined by in vivo bioluminescence imaging. Human Gene Therapy. 16: 1325-32. PMID 16259566 DOI: 10.1089/Hum.2005.16.1325  0.696
2005 Osborn MJ, Panoskaltsis-Mortari A, McElmurry RT, Bell SK, Vignali DA, Ryan MD, Wilber AC, McIvor RS, Tolar J, Blazar BR. A picornaviral 2A-like sequence-based tricistronic vector allowing for high-level therapeutic gene expression coupled to a dual-reporter system. Molecular Therapy : the Journal of the American Society of Gene Therapy. 12: 569-74. PMID 15964244 DOI: 10.1016/J.Ymthe.2005.04.013  0.634
2005 Wangensteen KJ, Wilber A, Zeng G, Frandsen JL, McIvor RS, Ekker SC, Wang X. 1068. Luciferase as an In Vivo Reporter for Selective Liver Repopulation in Adult FAH-/- Mice Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.615  0.627
2005 Wilber A, Buckley S, Lakshmipathy U, Frandsen J, Cowan MJ, McIvor RS. 338. Non-Viral Gene Transfer into Hematopoietic Cells of Artemis Deficient ScidA Mice Using the Sleeping BeautyTransposon System|[ast]| Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.341  0.686
2005 Wilber A, Montoya F, Geurts AM, Largaespada DA, Lakshmipathy U, McIvor RS. 193. Direct Comparison of Integration Efficiency and Stable Gene Expression Mediated by the Sleeping Beauty Transposon System and by the PhiC31 Phage Integrase System in Cultured Human Fibroblasts and in Various Stem Cell Targets Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.196  0.688
2004 Wilber AC, Frandsen JL, Belur LR, Score PR, Geurts JL, Largaespada DA, Hackett PB, McIvor RS. 1042. RNA as a Source of Transposase for Sleeping Beauty-Mediated Transposition and Long-Term Expression in Somatic Cells and Tissues Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.987  0.756
2004 Wilber A, Armour G, Schneider MC. 474. The Barrier to Liposomal Transfection is Enhanced by DNASES Lacking Lysosomal-Targetting Glycosylation Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.370  0.347
Show low-probability matches.